Duke University Hospital, Investigational Drug Service — Durham, North Carolina

Duke University Hospital, Investigational Drug Service is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

Duke University Hospital, Investigational Drug Service has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders.

Sponsors: GlycoMimetics Incorporated.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Hospital, Investigational Drug Service?

Duke University Hospital, Investigational Drug Service has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Hospital, Investigational Drug Service conducted?

Duke University Hospital, Investigational Drug Service has 1 clinical trials on record. Their work covers Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders.

Is Duke University Hospital, Investigational Drug Service accredited by Crixeo Health?

Duke University Hospital, Investigational Drug Service has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Hospital, Investigational Drug Service?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.